AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Navigating Advanced Illness Goals And Treatment With Digital Engagement (NAVIGATE)

RecruitingNAAges 21 Years - anyAllNational University of Singapore
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this two-armed, parallel-design, pre-/post-intervention assessment clinical trial is to learn if a digital and interactive website helps to improve advance care planning (ACP) engagement among caregivers of patients with serious illness. The main questions it aims to answer are: Does the website increase ACP engagement of caregivers of patients with serious illness? Researchers will compare the digital and interactive website to the usual care (a digital booklet) to see if the digital intervention works to improve ACP engagement among caregivers. Participants who are caregivers will: * Be introduced to a digital website and asked to explore the site over the course of the study. * Complete four self-administered questionnaires (baseline, one-week, six-week, and six-month). Participants who are patients will not have any intervention assigned and will only have their obser

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
1\. Patient Participants Inclusion Criteria: 1. Singapore resident aged 21years and above, 2. patient able to identify one main caregiver in the care and medical decision-making for the patient; 3. patient able to communicate in either English, Chinese, Malay or Tamil; 4. patient meeting one of the following illness criteria: 4a. Patients with brain tumours: histological and/or radiological diagnosis of glioma or brain metastases. 4b. Patients with spontaneous intracerebral haemorrhage (SICH) based on radiological diagnosis of SICH on baseline computed-tomographic scans. 4c. Patients with CKD Stage 4 and 5, identified at G4 or G5 of CKD, glomerular filtration rate (GFR) 30 ml/min or less, inclusive of kidney failure on kidney replacement therapy; and (5) Physicians assessment that ACP is appropriate for the patient by physicians.\* (\*) The attending clinicians may base the assessment of ACP appropriateness on several factors in addition to high mortality risk. As a baseline, clinicians are asked to base their assessment of high mortality risk using the validated "Surprise" question. 2\. Patient participants Exclusion Criteria: 1. Patients unable to identify a caregiver who is a medical decision-maker, 2. Patients are currently or was previously healthcare workers; or 3. Patients are diagnosed with dementia or deemed cognitively impaired as determined by the Abbreviated Mental Test. 3\. Caregiver Participants Inclusion Criteria: 1. caregivers are identified as a medical decision-maker for the patient 2. Singapore resident aged 21 years and above; and 3. able to communicate in English 4\. Caregiver Participants Exclusion Criteria: 1. caregivers are currently or were previously healthcare workers; 2. caregivers not involved in primary care of the patient (including providing care to the patient, supervision of care, or involved in making decisions regarding treatment the patient receives); or 3. caregivers diagnosed with dementia.
๐Ÿ’Š

What it tests

  • Careverse
  • Usual Care
๐Ÿ“

Where

1 site
National University Hospital
Singapore, Singapore
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy